Vir Biotechnology Inc at Morgan Stanley Global Healthcare Conference Transcript
All right. Good morning, everyone and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Michael Ulz, one of the biotech analysts here and it's my pleasure to introduce the team from Vir Biotechnology, including Marianne De Backer, CEO; and Sung Lee, CFO. Just as a reminder, the format for today is a fireside chat. So if anyone in the audience has a question, please feel free to raise your hand and we'll address your question, although with these lights, I'm not sure I can see if people raise their hands but give it a go.
Before we get started, I just need to read a quick disclosure. For important disclosures, please see the Morgan Stanley Research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. And with that, Marianne and Sung, thanks for joining us today.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |